•Inflammatory bowel disease must be a policy priority after the 2025 United Nations declaration on non-communicable diseases and mental health
•Adjunctive GLP1 Receptor Agonists in Patients with Inflammatory Bowel Diseases and Obesity and/or Diabetes: A Target Trial Emulation
•Glucocorticoid-induced Leucine Zipper (GILZ) is a novel secreted protein by intestinal L-cells and is dysregulated during active ulcerative colitis
•Update on Diet and Nutritional Therapies in Patients with Inflammatory Bowel Disease
•TIM3 signaling in effector T cells acts as an immunometabolic switch in the purine degradation pathway to suppress intestinal inflammation
